Regression of metastatic non-small-cell lung cancer in a chemonaive patient treated with gefitinib ('Iressa', ZD1839)

被引：0
|
作者：
Petruzelka, L [1 ]
Zemanova, M [1 ]
机构：
[1] Charles Univ Prague, Univ Hosp, Prague, Czech Republic
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [21] Long-term disease stabilisation with gefitinib ('Iressa', ZD1839) treatment in a patient with advanced non-small-cell lung cancer and multiple metastatic sites
    van der Kamp, R
    Koolen, MGJ
    Jansen, HM
    BRITISH JOURNAL OF CANCER, 2003, 89 : S34 - S34
  • [22] Commentary on ZD1839 (Iressa) in non small lung cancer
    Ranson, M
    Thatcher, N
    LUNG CANCER, 2003, 40 (01) : 77 - 78
  • [23] An elderly patient with extensive non-small-cell lung cancer was effectively treated with first-line gefitinib ('Iressa', ZD1839) followed by combined chemotherapy
    Pesek, M
    Eliasova, B
    BRITISH JOURNAL OF CANCER, 2003, 89 : S31 - S31
  • [24] A case of diffuse interstitial pneumonitis in a patient with stage IV non-small-cell lung cancer receiving gefitinib ('Iressa', ZD1839) treatment
    Gervais, R
    Chasles, J
    Rivière, A
    Michels, JJ
    BRITISH JOURNAL OF CANCER, 2003, 89 : S28 - S29
  • [25] Activity of the epidermal growth factor receptor inhibitor gefitinib ('Iressa', ZD1839) in refractory non-small-cell lung cancer
    Parra, HS
    Cavina, R
    Zucali, P
    Campagnoli, E
    Latteri, F
    Biancofiore, G
    Abbadessa, G
    Morenghi, E
    Santoro, A
    BRITISH JOURNAL OF CANCER, 2003, 89 : S33 - S33
  • [26] Gefitinib ('Iressa', ZD1839) in patients with brain metastases from non-small-cell lung cancer:: report of four cases
    Cappuzzo, F
    Ardizzoni, A
    Soto-Parra, H
    Gridelli, C
    Maione, P
    Tisea, M
    Calandri, C
    Bartolini, S
    Santoro, A
    Crinò, L
    BRITISH JOURNAL OF CANCER, 2003, 89 : S26 - S26
  • [27] Gefitinib ('Iressa', ZD1839) as third-line therapy for a patient with symptomatic brain metastases from non-small-cell lung cancer
    Azémar, M
    Stoll, C
    Unger, C
    BRITISH JOURNAL OF CANCER, 2003, 89 : S25 - S25
  • [28] Treatment of non-small-cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use programme
    Razis, Evangelia
    Skarlos, Dimosthenis V.
    Briassoulis, Evangelos
    Dimopoulos, Meletios
    Fountzilas, George
    Lambropoulos, Stefanos
    Rigatos, Sotiris
    Kopteridis, P.
    Efstathiou, Helen
    Kosmidis, Paris
    ANNALS OF ONCOLOGY, 2004, 15 : 183 - 183
  • [29] Gefitinib ('Iressa', ZD1839) in patients with brain metastases from non-small-cell lung cancer:: report of four cases
    Cappuzzo, F
    Calandri, C
    Bartolini, S
    Crinò, L
    BRITISH JOURNAL OF CANCER, 2003, 89 : S26 - S26
  • [30] Activity of a specific inhibitor, gefitinib (Iressa™, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
    Santoro, A
    Cavina, R
    Latteri, F
    Zucali, PA
    Ginanni, V
    Campagnoli, E
    Ferrari, B
    Morenghi, E
    Pedicini, V
    Roncalli, A
    Alloisio, M
    Ravasi, G
    Parral, HJS
    ANNALS OF ONCOLOGY, 2004, 15 (01) : 33 - 37
12345